Thrombospondin 1, fibronectin, and vitronectin are differentially dependent upon RAS, ERK1/2, and p38 for induction of vascular smooth muscle cell chemotaxis

Vascular and Endovascular Surgery

Volumn 45, Issue 1, 2011, Pages 55-62

  Willis, Alliric I ^a   Sadowitz, Benjamin ^b,c   Fuse, Shoichi ^a   Maier, Kristopher G ^b,c   Lee, Tae S ^a   Wang, Xiu Jie ^a   Tuszynski, George P ^d   Sumpio, Bauer E ^a,e   Gahtan, Vivian ^a,b,c,e  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^c VA Healthcare Network Upstate New York   (United States)

^d TEMPLE UNIVERSITY   (United States)

^e VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

Author keywords

chemotaxis; extracellular matrix; fibronectin; mitogen activated protein kinase; ras; thrombospondin 1; vascular smooth muscle cells; vitronectin

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 HYDROXYPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; DIMETHYL SULFOXIDE; FIBRONECTIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN FARNESYLTRANSFERASE INHIBITOR; PROTEIN SERINE THREONINE KINASE; RAS PROTEIN; THROMBOSPONDIN 1; VITRONECTIN;

ANIMAL CELL; ARTICLE; CELL MIGRATION; CELL MOTION; CONTROLLED STUDY; GENETIC TRANSFECTION; NONHUMAN; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

ANALYSIS OF VARIANCE; ANIMALS; CATTLE; CELLS, CULTURED; CHEMOTAXIS; FIBRONECTINS; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTEIN KINASE INHIBITORS; RAS PROTEINS; THROMBOSPONDIN 1; TRANSFECTION; VITRONECTIN;

EID: 78650806309     PISSN: 15385744     EISSN: None     Source Type: Journal    
DOI: 10.1177/1538574410387677     Document Type: Article

References (32)

1. Parent CA, Devreotes PN A Cell's Sense of Direction. Science. 1999 ; 284 (5415). 765-770.
2. Davies MD, Hagen PO Pathobiology of intimal hyperplasia. Br J Surg. 1994 ; 81 (8). 1254-1269.
3. Stossel TP The machinery of cell crawling. Sci Am. 1994 ; 271 (13). 54-55, 58-63.
4. Nelson PR, Yamamura S., Kent KC Extracellular matrix proteins are potent agonists of human smooth muscle cell migration. J Vasc Surg. 1996 ; 24 (1). 25-33.
5. van Aken BE, Seiffert D., Thinnes T., Loskutoff DJ Localization of vitronectin in the normal and atherosclerotic human vessel wall. Histochem Cell Biol. 1997 ; 107 (4). 313-320.
6. Magnusson MK, Mosher DF Fibronectin: Structure, Assembly, and Cardiovascular Implications. Arterioscler Thromb Vasc Biol. 1998 ; 18 (9). 1363-1370.
7. Roth JJ, Gahtan V., Brown JL, et al. Thrombospondin-1 is elevated with both intimal hyperplasia and hypercholesterolemia. J Surg Res. 1998 ; 74 (1). 11-16.
8. Gahtan V., Wang XJ, Willis AI, Tuszynski GP, Sumpio BE Thrombospondin-1 regulation of smooth muscle cell chemotaxis is extracellular signal-regulated protein kinases 1/2 dependent. Surgery. 1999 ; 126 (2). 203-207.
9. Fuse S., Esemuede N., Yamaguchi MS, et al. The role of G proteins in thrombospondin-1-induced vascular smooth muscle cell migration. Surgery. 2008 ; 144 (1). 86-92.
10. Esemuede N., Lee T., Maier KG, et al. Lovastatin inhibits thrombospondin-1-induced smooth muscle cell chemotaxis. J Surg Res. Epub 2009 (IN PRESS).
11. Wang XJ, Willis AI, Kito H., et al. Thrombospondin-1 induces p38 activation in vascular smooth muscle cells. FASEB J. 1999 ; 13 (3). A436.
12. Wang XJ, Maier K., Willis AI, et al. Thrombospondin-1-induced migration is functionally dependent upon focal adhesion kinase. Vascular and Endovascular Surgery. 2008 ; 42 (3). 256-262.
13. Lee TS, Nesselroth SM, Olson ET, et al. Thrombospondin-1-induced vascular smooth muscle cell chemotaxis: The role of the type 3 repeat and carboxyl terminal domains. J Cell Biochem. 2003 ; 89 (3). 500-506.
14. Campbell SL, Khosravi-Far R., Rossman KL, Clark GJ, Der CJ Increasing complexity of Ras signaling. Oncogene. 1998 ; 17 (11). 1395-1413.
15. Robinson MJ, Cobb MH Mitogen-activated protein kinase pathways. Curr Opin Cell Biol. 1997 ; 9 (5). 180-186.
16. Willis AI, Fuse S., Wang XJ, et al. Inhibition of phosphatidylinositol-3- kinase and protein kinase C attenuates extracellular matrix protein-induced vascular smooth muscle cell chemotaxis. J Vasc Surg. 2000 ; 31 (6). 1160-1167.
17. Seymour K., Han X., Sadowitz B., et al. Differential effect of nitric oxide on thrombospondin-1-, PDGF-, and fibronectin-induced migration of vascular smooth muscle cells. Am J Surg. 2010 ; Accepted (IN PRESS).
18. Maier KG, Sadowitz B., Cullen S., Han X., Gahtan V. Thrombospondin-1- induced vascular smooth muscle cell migration is dependent on the hyaluronic acid receptor CD44. The American Journal of Surgery. 2009 ; 198 (5). 664-669.
19. Shirai H., Autieri M., Eguchi S. Small GTP-binding proteins and mitogen-activated protein kinases as promising therapeutic targets of vascular remodeling. Curr Opin Nephrol Hypertens. 2007 ; 16 (2). 111-115.
20. Li C., Hu Y., Sturm G., Xu Q. Ras/Rac-dependent activation of p38 mitogen-activated protein kinases in smooth muscle cells stimulated by cyclic strain stress. Arterioscler Thromb Vasc Biol. 2000 ; 20 (3). e1 - e9.
21. Koyama H., Olson NE, Dastvan FF, Reidy MA Cell replication in the arterial wall: activation of signaling pathway following an in vivo injury. Circ Res. 1998 ; 82 (6). 713-721.
22. Graf K., Xi XP, Yang D., Fleck E., Hsueh WA, Law RE Mitogen-activated protein kinase activation is involved in platelet-derived growth factor-directed migration by vascular smooth muscle cells. Hypertension. 1997 ; 29 (1pt2). 334-339.
23. Nelson PR, Yamamura S., Mureebe L., Itoh H., Kent KC Smooth muscle cell migration and proliferation are mediated by distinct phases of activation of the intracellular messenger mitogen-activated protein kinase. J Vasc Surg. 1998 ; 27 (1). 117-125.
24. Pukac L., Huangpu J., Karnovsky MJ Platelet-derived growth factor-BB, insulin-like growth factor-1, and phorbol ester activate different signaling pathways for stimulation of vascular smooth muscle cell migration. Exp Cell Res. 1998 ; 242 (2). 548-560.
25. Klemke RL, Cai S., Giannini AL, Gallagher PJ, de Lanerolle P., Cheresh DA Regulation of cell motility by mitogen-activated protein kinase. J Cell Biol. 1997 ; 137 (2). 481-492.
26. Servant MJ, Giasson E., Meloche S. Inhibition of growth factor-induced protein synthesis by a selective MEK inhibitor in aortic smooth muscle cells. J Biol Chem. 1996 ; 271 (27). 16047-16052. (Pubitemid 26236218)
27. Di Luozzo G., Pradhan S., Dhadwal AK, Chen A., Ueno H., Sumpio BE Nicotine induces mitogen-activated protein kinase dependent vascular smooth muscle cell migration. Atherosclerosis. 2005 ; 178 (2). 271-277.
28. Itoh H., Nelson PR, Kaiura TL, Kent KC Distinct signaling pathways mediate extracellular matrix protein versus platelet-derived growth factor-induced smooth muscle cell migration. Surg Forum. 1998 ; XLIX (2). 311.
29. He Q., LaPointe M. Interleukin-1beta regulates the human brain natriuretic peptide promoter via Ca2+-dependent protein kinase pathways. Hypertension. 2000 ; 35 [part 2 ]: 292-296.
30. Awane M., Andres PG, Li DJ, Reinecker HC NF-{kappa}B-inducing kinase is a common mediator of IL-17, TNF-{alpha}-, and IL-1-{beta}-induced chemokine promoter activation in intestinal epithelial cells. J Immunol. 1999 ; 162 (9). 5337-5344.
31. Landry J., Huot J. Modulation of actin dynamics during stress and physiological stimulation by a signaling pathway involving p38 MAP kinase. Biochem Cell Biol. 1995 ; 73 (9-10). 703-707.
32. Li S., Tanaka H., Wang HH, et al. Intracellular signal transduction for migration and actin remodeling in vascular smooth muscle cells after sphingosylphosphorylcholine stimulation. American Journal of Physiology - Heart and Circulatory Physiology. 2006 ; 291 (3). H1262 - H1272.